Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2022
>
RSV Vaccine Candidate Granted Fast-Track Status for Seniors
RSV Vaccine Candidate Granted Fast-Track Status for Seniors
Read also
Bio AgeLabs
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
Vertex
Vertex's Casgevy breaks ground with 1st commercial patient infusions as company readies another major launch for 2025
Nektar
Nektar Therapeutics to sell Alabama facility to Ampersand
Scholar Rock
Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin
